Challenges in Clinical Electrocardiography.Proportions of Patients With Clinically Relevant Declines in Sexual and Hormonal Expanded Prostate Cancer Index Composite (EPIC-26) Scores Longitudinal Changes in Sexual and Hormonal Expanded Prostate Cancer Index Composite (EPIC-26) ScoresĮFigure 5. Longitudinal Changes in Total International Prostate Symptom Score (IPSS) and IPSS Quality-of-Life ScoresĮFigure 4. Proportions of Patients With Clinically Relevant Declines in Expanded Prostate Cancer Index Composite-26 (EPIC-26) Scores Urinary SubdomainsĮFigure 3. Longitudinal Changes in Urinary Irritative/Obstructive and Total Urinary Expanded Prostate Cancer Index Composite-26 (EPIC-26) ScoresĮFigure 2. Acute Grade ≥2 Genitourinary and Gastrointestinal Toxicity Rates in Selected Other Stereotactic Body Radiotherapy StudiesĮFigure 1. Differences in Grade ≥2 Genitourinary and Gastrointestinal Toxicities Stratified by Baseline Prostate VolumeĮTable 7. Differences in Grade ≥2 Genitourinary and Gastrointestinal Toxicities Stratified by Baseline International Prostate Symptom Score (IPSS)ĮTable 6. Multivariate Analysis for Acute Grade ≥2 Genitourinary ToxicitiesĮTable 5. Sensitivity Analysis for Differences in Acute Genitourinary and Gastrointestinal Toxicity Including Patients Not Who Were Analyzed But Not EvaluableĮTable 4. Comparison of Dosimetric Parameters Between CT- and MRI-Guided ArmsĮTable 3. Details on Treatment Delivery TimesĮTable 2.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |